Medinice S.A (ICE) - Total Liabilities

Latest as of December 2025: zł4.62 Million PLN ≈ $1.27 Million USD

Based on the latest financial reports, Medinice S.A (ICE) has total liabilities worth zł4.62 Million PLN (≈ $1.27 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Medinice S.A to track the company's year-over-year net asset growth rate.

Medinice S.A - Total Liabilities Trend (2016–2025)

This chart illustrates how Medinice S.A's total liabilities have evolved over time, based on quarterly financial data. See Medinice S.A free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Medinice S.A Competitors by Total Liabilities

The table below lists competitors of Medinice S.A ranked by their total liabilities.

Company Country Total Liabilities
Smart Parking Ltd
AU:SPZ
Australia AU$42.15 Million
Tumosan Motor ve Traktor Sanayi AS
IS:TMSN
Turkey TL12.82 Billion
SHIPPING CORPORATION OF INDIA LAND
NSE:SCILAL
India Rs5.45 Billion
Taiwan Kong King Co Ltd
TWO:3093
Taiwan NT$627.88 Million
MSP Steel & Power Limited
NSE:MSPL
India Rs5.90 Billion
Remedy Entertainment Oyj
HE:REMEDY
Finland €31.42 Million
Favite Inc
TW:3535
Taiwan NT$616.49 Million
Steamships Trading Company Ltd
AU:SST
Australia AU$785.45 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Medinice S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ICE market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 6.87 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.05 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.05 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medinice S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medinice S.A (2016–2025)

The table below shows the annual total liabilities of Medinice S.A from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 zł4.62 Million
≈ $1.27 Million
-17.50%
2024-12-31 zł5.59 Million
≈ $1.54 Million
+29.28%
2023-12-31 zł4.33 Million
≈ $1.19 Million
-9.31%
2022-12-31 zł4.77 Million
≈ $1.31 Million
-44.50%
2021-12-31 zł8.60 Million
≈ $2.37 Million
+118.03%
2020-12-31 zł3.94 Million
≈ $1.09 Million
+14.06%
2019-12-31 zł3.46 Million
≈ $951.41K
-25.43%
2018-12-31 zł4.64 Million
≈ $1.28 Million
+183.09%
2017-12-31 zł1.64 Million
≈ $450.70K
+25.54%
2016-12-31 zł1.30 Million
≈ $359.00K
--

About Medinice S.A

WAR:ICE Poland Medical Devices
Market Cap
$209.58 Million
zł761.50 Million PLN
Market Cap Rank
#16365 Global
#105 in Poland
Share Price
zł82.00
Change (1 day)
+2.76%
52-Week Range
zł8.50 - zł90.20
All Time High
zł90.20
About

Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technol… Read more